Northern Trust’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.13M | Buy |
499,424
+81,339
| +19% | +$347K | ﹤0.01% | 2945 |
|
|
2025
Q1 | $1.57M | Sell |
418,085
-5,702
| -1% | -$21.4K | ﹤0.01% | 3048 |
|
|
2024
Q4 | $2.47M | Buy |
423,787
+34,053
| +9% | +$199K | ﹤0.01% | 2904 |
|
|
2024
Q3 | $4.65M | Buy |
389,734
+45,652
| +13% | +$545K | ﹤0.01% | 2519 |
|
|
2024
Q2 | $3.72M | Sell |
344,082
-5,075
| -1% | -$54.9K | ﹤0.01% | 2557 |
|
|
2024
Q1 | $3.95M | Sell |
349,157
-3,661
| -1% | -$41.4K | ﹤0.01% | 2609 |
|
|
2023
Q4 | $4.95M | Buy |
352,818
+51,493
| +17% | +$722K | ﹤0.01% | 2525 |
|
|
2023
Q3 | $3.72M | Buy |
301,325
+6,569
| +2% | +$81.1K | ﹤0.01% | 2613 |
|
|
2023
Q2 | $2.66M | Buy |
294,756
+221,764
| +304% | +$2M | ﹤0.01% | 2842 |
|
|
2023
Q1 | $253K | Buy |
72,992
+5,374
| +8% | +$18.6K | ﹤0.01% | 3748 |
|
|
2022
Q4 | $166K | Sell |
67,618
-117
| -0.2% | -$287 | ﹤0.01% | 3946 |
|
|
2022
Q3 | $187K | Buy |
67,735
+7,535
| +13% | +$20.8K | ﹤0.01% | 3902 |
|
|
2022
Q2 | $245K | Sell |
60,200
-170,683
| -74% | -$695K | ﹤0.01% | 3816 |
|
|
2022
Q1 | $983K | Sell |
230,883
-20,225
| -8% | -$86.1K | ﹤0.01% | 3422 |
|
|
2021
Q4 | $2.35M | Buy |
251,108
+4,843
| +2% | +$45.3K | ﹤0.01% | 3145 |
|
|
2021
Q3 | $6.79M | Buy |
246,265
+112,823
| +85% | +$3.11M | ﹤0.01% | 2543 |
|
|
2021
Q2 | $3.73M | Buy |
133,442
+3,334
| +3% | +$93.3K | ﹤0.01% | 3011 |
|
|
2021
Q1 | $4.32M | Buy |
130,108
+116,206
| +836% | +$3.86M | ﹤0.01% | 2843 |
|
|
2020
Q4 | $668K | Buy |
+13,902
| New | +$668K | ﹤0.01% | 3645 |
|